PRALIDOXIME CHLORIDE - Generic Drug Details
✉ Email this page to a colleague
What are the generic sources for pralidoxime chloride and what is the scope of freedom to operate?
Pralidoxime chloride
is the generic ingredient in three branded drugs marketed by Baxter Hlthcare Corp, Meridian Medcl Techn, and Wyeth Ayerst, and is included in four NDAs. Additional information is available in the individual branded drug profile pages.There are five drug master file entries for pralidoxime chloride. One supplier is listed for this compound.
Summary for PRALIDOXIME CHLORIDE
| US Patents: | 0 |
| Tradenames: | 3 |
| Applicants: | 3 |
| NDAs: | 4 |
| Drug Master File Entries: | 5 |
| Finished Product Suppliers / Packagers: | 1 |
| Raw Ingredient (Bulk) Api Vendors: | 116 |
| Clinical Trials: | 1 |
| Patent Applications: | 1,312 |
| What excipients (inactive ingredients) are in PRALIDOXIME CHLORIDE? | PRALIDOXIME CHLORIDE excipients list |
| DailyMed Link: | PRALIDOXIME CHLORIDE at DailyMed |
Recent Clinical Trials for PRALIDOXIME CHLORIDE
Identify potential brand extensions & 505(b)(2) entrants
| Sponsor | Phase |
|---|---|
| Sir Salimullah Medical College Mitford Hospital | Phase 2 |
Pharmacology for PRALIDOXIME CHLORIDE
| Drug Class | Cholinesterase Reactivator |
| Mechanism of Action | Cholinesterase Reactivators |
Anatomical Therapeutic Chemical (ATC) Classes for PRALIDOXIME CHLORIDE
US Patents and Regulatory Information for PRALIDOXIME CHLORIDE
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Wyeth Ayerst | PROTOPAM CHLORIDE | pralidoxime chloride | TABLET;ORAL | 014122-002 | Approved Prior to Jan 1, 1982 | DISCN | No | No | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | ||||
| Baxter Hlthcare Corp | PROTOPAM CHLORIDE | pralidoxime chloride | INJECTABLE;INJECTION | 014134-001 | Approved Prior to Jan 1, 1982 | RX | Yes | Yes | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | ||||
| Meridian Medcl Techn | PRALIDOXIME CHLORIDE (AUTOINJECTOR) | pralidoxime chloride | SOLUTION;INTRAMUSCULAR | 018986-001 | Apr 26, 1983 | DISCN | Yes | No | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | ||||
| Baxter Hlthcare Corp | PRALIDOXIME CHLORIDE | pralidoxime chloride | INJECTABLE;INJECTION | 018799-001 | Dec 13, 1982 | DISCN | No | No | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | ||||
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
Expired US Patents for PRALIDOXIME CHLORIDE
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | Patent No. | Patent Expiration |
|---|---|---|---|---|---|---|---|
| Baxter Hlthcare Corp | PRALIDOXIME CHLORIDE | pralidoxime chloride | INJECTABLE;INJECTION | 018799-001 | Dec 13, 1982 | ⤷ Sign Up | ⤷ Sign Up |
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >Patent No. | >Patent Expiration |
Make Better Decisions: Try a trial or see plans & pricing
Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.
ISSN: 2162-2639
Privacy and Cookies
Terms & Conditions
Site Map
DrugPatentWatch Alternatives
LOE / Major Patent Expirations 2024 - 2025
NCE-1 Patent Challenge Dates 2024 - 2025
Trigger-based marketing for the life sciences
Get DrugPatentWatch Business Intelligence Reports at Amazon.com
DrugChatter - AI-based answers to questions about drugs
RxJam - Digital Marketing for Life Sciences
Friedman, Yali. "DrugPatentWatch" DrugPatentWatch, thinkBiotech, 2024, www.DrugPatentWatch.com.
See Primary Research Papers Citing DrugPatentWatch
Follow DrugPatentWatch:
